Header Logo

Connection

Jonathan Levin to Female

Back to Details
This is a "connection" page, showing publications Jonathan Levin has written about Female.
Jonathan Levin
Connection Strength
1,336
Female
  1. Combining national survey with facility-based HIV testing data to obtain more accurate estimate of HIV prevalence in districts in Uganda. BMC Public Health. 2020 Mar 23; 20(1):379.
    View in: PubMed
    Score: 0,066
  2. Difference in HIV prevalence by testing venue: results from population level survey in Uganda. AIDS Care. 2021 03; 33(3):273-284.
    View in: PubMed
    Score: 0,066
  3. Factors associated with recovery from stunting among under-five children in two Nairobi informal settlements. PLoS One. 2019; 14(4):e0215488.
    View in: PubMed
    Score: 0,062
  4. Health-care utilization and associated factors in Gauteng province, South Africa. Glob Health Action. 2017; 10(1):1305765.
    View in: PubMed
    Score: 0,053
  5. Prevalence and risk factors of depression in childhood and adolescence as seen in four districts of North-Eastern Uganda. BMC Int Health Hum Rights. 2013 Apr 05; 13:19.
    View in: PubMed
    Score: 0,041
  6. In utero and intra-partum HIV-1 transmission and acute HIV-1 infection during pregnancy: using the BED capture enzyme-immunoassay as a surrogate marker for acute infection. Int J Epidemiol. 2011 Aug; 40(4):945-54.
    View in: PubMed
    Score: 0,036
  7. The impact of age on the epidemiology of incomplete abortions in South Africa after legislative change. BJOG. 2005 Mar; 112(3):355-9.
    View in: PubMed
    Score: 0,023
  8. Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study. S Afr Med J. 2004 Aug; 94(8):647-51.
    View in: PubMed
    Score: 0,022
  9. Labour induction at term--a randomised trial comparing Foley catheter plus titrated oral misoprostol solution, titrated oral misoprostol solution alone, and dinoprostone. S Afr Med J. 2003 May; 93(5):375-9.
    View in: PubMed
    Score: 0,021
  10. Factors associated with sexual and reproductive health service utilisation in high migration communities in six Southern African countries. BMC Public Health. 2022 05 02; 22(1):876.
    View in: PubMed
    Score: 0,019
  11. Infection-exposure in infancy is associated with reduced allergy-related disease in later childhood in a Ugandan cohort. Elife. 2021 09 22; 10.
    View in: PubMed
    Score: 0,018
  12. Analysis of multivariate longitudinal immuno-epidemiological data using a pairwise joint modelling approach. BMC Immunol. 2021 09 17; 22(1):63.
    View in: PubMed
    Score: 0,018
  13. Prevalence and factors associated with catastrophic health expenditure among slum and non-slum dwellers undergoing emergency surgery in a metropolitan area of South Western Nigeria. PLoS One. 2021; 16(8):e0255354.
    View in: PubMed
    Score: 0,018
  14. Effect of suicidality on clinical and behavioural outcomes in HIV positive adults in Uganda. PLoS One. 2021; 16(8):e0254830.
    View in: PubMed
    Score: 0,018
  15. Model-based small area estimation methods and precise district-level HIV prevalence estimates in Uganda. PLoS One. 2021; 16(8):e0253375.
    View in: PubMed
    Score: 0,018
  16. Beliefs and perceptions regarding cervical cancer and screening associated with Pap smear uptake in Johannesburg: A cross-sectional study. PLoS One. 2021; 16(2):e0246574.
    View in: PubMed
    Score: 0,018
  17. Migrants' perceptions of health system responsiveness and satisfaction with health workers in a South African Province. Glob Health Action. 2020 12 31; 13(1):1850058.
    View in: PubMed
    Score: 0,018
  18. Major Depressive Disorder Among HIV Infected Youth in Uganda: Incidence, Persistence and Their Predictors. AIDS Behav. 2020 Sep; 24(9):2588-2596.
    View in: PubMed
    Score: 0,017
  19. Mycobacterium tuberculosis infection is associated with increased B cell responses to unrelated pathogens. Sci Rep. 2020 08 31; 10(1):14324.
    View in: PubMed
    Score: 0,017
  20. Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy. J Infect Dis. 2020 07 06; 222(3):381-390.
    View in: PubMed
    Score: 0,017
  21. Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda. Front Immunol. 2020; 11:929.
    View in: PubMed
    Score: 0,017
  22. Effectiveness of a multi-level intervention to reduce men's perpetration of intimate partner violence: a cluster randomised controlled trial. Trials. 2020 Apr 25; 21(1):359.
    View in: PubMed
    Score: 0,017
  23. Decision space and participation of primary healthcare facility managers in the Ideal Clinic Realisation and Maintenance programme in two South African provinces. Health Policy Plan. 2020 Apr 01; 35(3):302-312.
    View in: PubMed
    Score: 0,017
  24. Epidemiology and clinical profile of individuals with cleft lip and palate utilising specialised academic treatment centres in South Africa. PLoS One. 2019; 14(5):e0215931.
    View in: PubMed
    Score: 0,016
  25. Analysing child linear growth trajectories among under-5 children in two Nairobi informal settlements. Public Health Nutr. 2019 08; 22(11):2001-2011.
    View in: PubMed
    Score: 0,016
  26. Rates, types and co-occurrence of emotional and behavioural disorders among perinatally HIV-infected youth in Uganda: the CHAKA study. Soc Psychiatry Psychiatr Epidemiol. 2019 Apr; 54(4):415-425.
    View in: PubMed
    Score: 0,015
  27. Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial. PLoS One. 2018; 13(12):e0206907.
    View in: PubMed
    Score: 0,015
  28. Compassion satisfaction, burnout and secondary traumatic stress among termination of pregnancy providers in two South African provinces. J Obstet Gynaecol Res. 2018 Jul; 44(7):1202-1210.
    View in: PubMed
    Score: 0,015
  29. Health care providers' compliance with the notifiable diseases surveillance system in South Africa. PLoS One. 2018; 13(4):e0195194.
    View in: PubMed
    Score: 0,014
  30. Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011. Pan Afr Med J. 2018; 29:191.
    View in: PubMed
    Score: 0,014
  31. Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda. BMC Immunol. 2018 01 03; 19(1):1.
    View in: PubMed
    Score: 0,014
  32. Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responses. PLoS One. 2017; 12(11):e0188396.
    View in: PubMed
    Score: 0,014
  33. RELATIONSHIP BETWEEN ORPHANHOOD STATUS, LIVING ARRANGEMENTS AND SEXUAL DEBUT: EVIDENCE FROM FEMALES IN MIDDLE ADOLESCENCE IN SOUTHERN AFRICA. J Biosoc Sci. 2018 05; 50(3):380-396.
    View in: PubMed
    Score: 0,014
  34. Prevalence and correlates for ADHD and relation with social and academic functioning among children and adolescents with HIV/AIDS in Uganda. BMC Psychiatry. 2017 09 22; 17(1):336.
    View in: PubMed
    Score: 0,014
  35. The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study. BMC Palliat Care. 2017 Jul 13; 17(1):8.
    View in: PubMed
    Score: 0,014
  36. Incidence and Persistence of Major Depressive Disorder Among People Living with HIV in Uganda. AIDS Behav. 2017 Jun; 21(6):1641-1654.
    View in: PubMed
    Score: 0,014
  37. The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial. PLoS Negl Trop Dis. 2017 May; 11(5):e0005440.
    View in: PubMed
    Score: 0,014
  38. COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort. AIDS Res Ther. 2017; 14:26.
    View in: PubMed
    Score: 0,014
  39. Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda. Reprod Health. 2017 Mar 11; 14(1):36.
    View in: PubMed
    Score: 0,013
  40. Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults. AIDS. 2017 02 20; 31(4):577-582.
    View in: PubMed
    Score: 0,013
  41. Humoral Responses to Rv1733c, Rv0081, Rv1735c, and Rv1737c DosR Regulon-Encoded Proteins of Mycobacterium tuberculosis in Individuals with Latent Tuberculosis Infection. J Immunol Res. 2017; 2017:1593143.
    View in: PubMed
    Score: 0,013
  42. Major depressive disorder and suicidality in early HIV infection and its association with risk factors and negative outcomes as seen in semi-urban and rural Uganda. J Affect Disord. 2017 Apr 01; 212:117-127.
    View in: PubMed
    Score: 0,013
  43. Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study. Malar J. 2016 07 15; 15:361.
    View in: PubMed
    Score: 0,013
  44. Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study. AIDS. 2016 Feb 20; 30(4):635-44.
    View in: PubMed
    Score: 0,013
  45. Factors associated with dropout in a long term observational cohort of fishing communities around lake Victoria, Uganda. BMC Res Notes. 2015 Dec 24; 8:815.
    View in: PubMed
    Score: 0,012
  46. Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections. AIDS Res Hum Retroviruses. 2016 Mar; 32(3):237-46.
    View in: PubMed
    Score: 0,012
  47. Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study. BMC Infect Dis. 2015 Oct 22; 15:438.
    View in: PubMed
    Score: 0,012
  48. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Med. 2015 May 29; 13:126.
    View in: PubMed
    Score: 0,012
  49. Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design. Contemp Clin Trials. 2015 Jul; 43:100-4.
    View in: PubMed
    Score: 0,012
  50. Hope: a new approach to understanding structural factors in HIV acquisition. Glob Public Health. 2015; 10(4):417-37.
    View in: PubMed
    Score: 0,012
  51. Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens. J Int Assoc Provid AIDS Care. 2015 Sep-Oct; 14(5):455-62.
    View in: PubMed
    Score: 0,011
  52. Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohort. PLoS One. 2014; 9(11):e111517.
    View in: PubMed
    Score: 0,011
  53. Effect of seasonal variation on adult clinical laboratory parameters in Rwanda, Zambia, and Uganda: implications for HIV biomedical prevention trials. PLoS One. 2014; 9(8):e105089.
    View in: PubMed
    Score: 0,011
  54. Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study. PLoS One. 2014; 9(3):e90614.
    View in: PubMed
    Score: 0,011
  55. Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4? cell counts: findings from a cluster-randomized trial. AIDS. 2014 Feb 20; 28(4):569-76.
    View in: PubMed
    Score: 0,011
  56. Comparison of methods for correction of mortality estimates for loss to follow-up after ART initiation: a case of the Infectious Diseases Institute, Uganda. PLoS One. 2013; 8(12):e83524.
    View in: PubMed
    Score: 0,011
  57. Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART. BMC Infect Dis. 2013 Aug 27; 13:395.
    View in: PubMed
    Score: 0,011
  58. Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda. Trials. 2013 Feb 01; 14:33.
    View in: PubMed
    Score: 0,010
  59. Trends in child mortality: a prospective, population-based cohort study in a rural population in south-west Uganda. Paediatr Int Child Health. 2013 Feb; 33(1):23-31.
    View in: PubMed
    Score: 0,010
  60. HIV-1 subtype distribution trends and evidence of transmission clusters among incident cases in a rural clinical cohort in southwest Uganda, 2004-2010. AIDS Res Hum Retroviruses. 2013 Mar; 29(3):520-7.
    View in: PubMed
    Score: 0,010
  61. Mortality of HIV-infected and uninfected children in a longitudinal cohort in rural south-west Uganda during 8 years of follow-up. Trop Med Int Health. 2012 Jul; 17(7):836-43.
    View in: PubMed
    Score: 0,010
  62. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. Lancet Infect Dis. 2011 Dec; 11(12):933-41.
    View in: PubMed
    Score: 0,009
  63. Examining the components of population-level sexual behavior trends from 1993 to 2007 in an open ugandan cohort. Sex Transm Dis. 2011 Aug; 38(8):697-704.
    View in: PubMed
    Score: 0,009
  64. Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda. PLoS One. 2011; 6(6):e20684.
    View in: PubMed
    Score: 0,009
  65. Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med. 2011 Mar; 8(3):e1000427.
    View in: PubMed
    Score: 0,009
  66. Decreasing trends of bacteraemia among HIV-infected Ugandan adults: incidence, aetiology, clinical outcomes and effect of antiretroviral therapy in a semi-urban setting (2000-2008). Trop Med Int Health. 2011 Jun; 16(6):756-65.
    View in: PubMed
    Score: 0,009
  67. Adolescent suicidality as seen in rural northeastern Uganda: prevalence and risk factors. Crisis. 2011; 32(1):43-51.
    View in: PubMed
    Score: 0,009
  68. Factors associated with consistent condom use among rural young women in South Africa. AIDS Care. 2010 Nov; 22(11):1379-85.
    View in: PubMed
    Score: 0,009
  69. Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment. Trop Med Int Health. 2010 Nov; 15(11):1347-56.
    View in: PubMed
    Score: 0,009
  70. Operational evaluation of a service for prevention of mother-to-child transmission of HIV in rural Uganda: barriers to uptake of single-dose nevirapine and the role of birth reporting. Trop Med Int Health. 2010 Oct; 15(10):1163-71.
    View in: PubMed
    Score: 0,009
  71. Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):245-52.
    View in: PubMed
    Score: 0,009
  72. Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. J Acquir Immune Defic Syndr. 2010 Apr 01; 53(4):496-9.
    View in: PubMed
    Score: 0,008
  73. Symptom burden in HIV-infected adults at time of HIV diagnosis in rural Uganda. J Palliat Med. 2010 Apr; 13(4):375-80.
    View in: PubMed
    Score: 0,008
  74. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009 Dec 19; 374(9707):2080-2089.
    View in: PubMed
    Score: 0,008
  75. Haematological and biochemistry laboratory abnormalities associated with splenomegaly in asymptomatic adults in Masaka, Uganda: implications for HIV biomedical prevention trials. Trop Med Int Health. 2010 Jan; 15(1):105-12.
    View in: PubMed
    Score: 0,008
  76. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009 Aug 11; 9:290.
    View in: PubMed
    Score: 0,008
  77. Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Trop Med Int Health. 2009 Feb; 14(2):196-203.
    View in: PubMed
    Score: 0,008
  78. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res. 2008 Nov 20; 8:241.
    View in: PubMed
    Score: 0,008
  79. Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis. 2008 Nov 01; 47(9):1126-34.
    View in: PubMed
    Score: 0,008
  80. Symptomatic hyperlactataemia in adults on antiretroviral therapy: a single-centre experience. S Afr Med J. 2008 Oct; 98(10):795-800.
    View in: PubMed
    Score: 0,007
  81. Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. J Acquir Immune Defic Syndr. 2008 Aug 01; 48(4):468-75.
    View in: PubMed
    Score: 0,007
  82. Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV. Bull World Health Organ. 2007 Jun; 85(6):466-73.
    View in: PubMed
    Score: 0,007
  83. Perpetration of partner violence and HIV risk behaviour among young men in the rural Eastern Cape, South Africa. AIDS. 2006 Oct 24; 20(16):2107-14.
    View in: PubMed
    Score: 0,007
  84. Reductions in blood lead levels among school children following the introduction of unleaded petrol in South Africa. Environ Res. 2006 Mar; 100(3):319-22.
    View in: PubMed
    Score: 0,006
  85. A community-based study to examine the effect of a youth HIV prevention intervention on young people aged 15-24 in South Africa: results of the baseline survey. Trop Med Int Health. 2005 Oct; 10(10):971-80.
    View in: PubMed
    Score: 0,006
  86. Blood manganese concentrations among first-grade schoolchildren in two South African cities. Environ Res. 2005 Jan; 97(1):93-9.
    View in: PubMed
    Score: 0,006
  87. Risk factors for domestic violence: findings from a South African cross-sectional study. Soc Sci Med. 2002 Nov; 55(9):1603-17.
    View in: PubMed
    Score: 0,005
  88. Prevalence of morbidity associated with abortion before and after legalisation in South Africa. BMJ. 2002 May 25; 324(7348):1252-3.
    View in: PubMed
    Score: 0,005
  89. Rape of girls in South Africa. Lancet. 2002 Jan 26; 359(9303):319-20.
    View in: PubMed
    Score: 0,005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.